Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Hydrosalpinx – To Treat or Not A. Strandell Reproductive Medicine Unit, Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gצteborg, Sweden Summary Several retrospective studies have shown an impaired outcome of in vitro fertilization (IVF) in the presence of hydrosalpinx. It is believed that the fluid exerts a detrimental effect on the endometrium by altering the receptivity or simply by causing a mechanical hindrance for implantation. Different treatment options would then be salpingectomy, tubal ligation, salpingostomy or aspiration of hydrosalpingeal fluid. Laparoscopic salpingectomy is the only procedure that has been evaluated in a randomized controlled trial and it was found to be beneficial in patients with large hydrosalpinges that were visible on ultrasound. Pregnancy and birth rates were twice as high among patients who underwent salpingectomy as compared with those without any surgery before IVF. Introduction Tubal factor infertility has been the major reason for treatment with IVF since the method’s introduction, but patients with hydrosalpinges have been identified as a subgroup with significantly impaired pregnancy outcome compared with patients suffering from other types of tubal damage. Data from retrospective studies have been compiled, demonstrating a reduction by half in clinical pregnancy and delivery rates and a doubled rate of spontaneous abortion in women with hydrosalpinx. The poor result of IVF in hydrosalpinx patients certainly suggests there is a need for further treatment. One of the main explanations has implied that the leakage of fluid into the uterine cavity creates an unfavorable endometrial environment to implantation and could also affect embryo development. Retrospective studies have indicated that the larger the hydrosalpinx, the worse the outcome after IVF, which raised the question of embryotoxic properties of the fluid. However, the results of embryo cultures in hydrosalpingeal fluid have been contradictory among murine models, and human embryo development did not express any toxic influence of hydrosalpingeal fluid. Obviously, the lack of substrate in pure hydrosalpingeal fluid is harmful to the embryo development, but the potential embryotoxic property of hydrosalpingeal fluid is still a controversy. It has also been suggested that the leakage of fluid to the uterine cavity causing a watery interface is enough to prevent implantation. 13 Strandell Whatever the exact mechanism, an interruption of the communicating hydrosalpinx seems suitable to improve the endometrial environment to implantation. The present article will explore the different treatment options and present the available evidence for each method. Treatment Options According to the theory that the hydrosalpingeal fluid plays a causative role, any surgical intervention interrupting the communication to the uterus would remove the leakage of the hydrosalpingeal fluid and restore pregnancy rates. Which are the theoretical options? Through the laparoscopic route, salpingectomy, distal salpingostomy and tubal ligation are available methods, but only salpingectomy has been evaluated in a randomized controlled trial. Transvaginal ultrasound-guided aspiration of the hydrosalpingeal fluid in combination with antibiotics has been suggested as a less invasive method. Salpingectomy Hitherto, salpingectomy is the only method of prophylactic surgery in patients with hydrosalpinx that has been evaluated in randomized controlled trials. Two studies were of small sizes and did not show any statistically significant differences in pregnancy rates (Dיchaud et al. 1998, Goldstein et al. 1998). A multicenter study conducted in Scandinavia, showed a significant improvement in pregnancy and birth rates after salpingectomy in patients with hydrosalpinges that were large enough to be visible on ultrasound before ovarian stimulation was initiated, when first cycle was considered (Strandell et al. 1999). Clinical pregnancy rates were 46% vs. 27% (p=0.049) and birth rates were 40% vs. 17% (p=0.040) in salpingectomized patients vs. patients without any surgical intervention. When all subsequent cycles were considered, including all patients regardless of the size of the hydrosalpinx, salpingectomy implied a doubled birth rate as compared to patients with persistent hydrosalpinges. Data revealed that the benefit of salpingectomy mainly affected patients with hydrosalpinges visible on ultrasound, and consequently, those are the only to be recommended prophylactic salpingectomy prior to IVF. The psychological aspect of removing the tubes in an infertile patient is very important and has to be considered. Even if it is obvious that the patient would benefit from salpingectomy, it is crucial that she is psychologically prepared to undergo the procedure. In some cases it takes one or several failed cycles before the patient is ready to give her consent. In cases of unilateral hydrosalpinx and a contralateral healthy tube, the chance of spontaneous conception after a unilateral salpingectomy may be 13 Strandell increased, as demonstrated by the Scandinavian study in which two patients conceived and gave birth after a unilateral procedure. Is there a risk of impaired ovarian function subsequent to a salpingectomy? Hitherto, only one recent study has shown an adverse effect on the ovary ipsilateral to a salpingectomy, due to ectopic pregnancy (Lass et al. 1998). However, there was no difference in the overall performance when the sides were not separated, which may suggest a compensatory mechanism in the contra lateral adnex. In a study including almost exclusively patients who were unilaterally salpingectomized due to ectopic pregnancy after IVF, no negative effect of surgery on response parameters was seen, nor was the operated side more affected (Dar et al. 2000). In a prospective study of 26 women, the cycles before and after prophylactic salpingectomy were compared and the ovarian response was assessed as the dose and duration of gonadotrophins and the number of retrieved and fertilized oocytes without any significant differences detectable in any of the measured outcomes. (Strandell et al. 2001). Obviously, there is no impairment of the overall ovarian function subsequent to salpingectomy. However, theoretically it seems important to be very cautious not to damage the vascular and nervous supply when performing a salpingectomy. Proximal tubal occlusion Is tubal ligation as effective as salpingectomy? There are no randomized trial to answer this question. Two retrospective studies have not been able to show any significant differences in pregnancy outcome, but the number of patients has been too low to allow for any conclusion. Surrey et al. investigated retrospectively 94 patients with tubal disease, of which 32 with hydrosalpinges were treated by salpingectomy prior to IVF and 15 were treated by tubal ligation regardless of adhesion status (Surrey et al. 2001). Implantation rates were 29 % and 19 % respectively (not statistically significant). In another retrospective study, 45 of 60 patients with hydrosalpinges accepted laparoscopic surgery, and salpingectomy was performed if possible, while tubal ligation and distal drainage was performed in cases of extensive adhesions (Stadtmauer et al. 2000). Only the surgically untreated group expressed significantly lower clinical pregnancy rates as compared with both salpingectomy and tubal ligation. Distal tubal repair Is there a risk of unnecessary salpingectomies being performed when a clear recommendation of salpingectomy has been formulated to a defined patient group? Hydrosalpinges with preserved mucosa may be better treated with reconstructive surgery as primary treatment instead of 13 Strandell salpingectomy and IVF. The latter option may, however, be the secondary treatment after failed conception and re-occlusion of the tubes. Unnecessary salpingectomies should, of course, not be performed and they may easily be avoided by appropriate evaluation of the tubal mucosa at laparoscopy before any final decision of salpingectomy is made. It is important that physicians discriminate carefully whether a hydrosalpinx should be removed or is suitable for surgical repair. A prerequisite is that the patient is well informed about the different treatment options, their success rates in terms of pregnancy outcome and also the risk of ectopic pregnancy. Tubal repair with distal salpingostomy or fimbrioplasty gives the patient the chance of a spontaneous conception. If conception does not occur, the surgical procedure might be of benefit when IVF is undertaken, unless the distal opening has re-occluded. However, there are no studies to prove this theory, only occasional cases as part of a control group in retrospective studies have been reported. Transvaginal aspiration The least invasive surgical method, transvaginal ultrasound-guided aspiration of fluid, has been described in several case reports and in two retrospective studies. Different conclusions regarding the benefit of drainage at the time of oocyte retrieval in terms of improved pregnancy and implantation rates were drawn (Sowter et al. 1997, VanVoorhis et al. 1998). The first and largest study showed no effect on pregnancy rates while the latter study showed a significant improvement. There is a rapid reoccurrence of fluid already noticeable at the time of transfer in many cases, which is likely to compromise any beneficial effect of drainage. Transvaginal aspiration before start of ovarian stimulation has been described without any improvement in pregnancy rates (Aboulghar et al. 1990). There is a need to properly evaluate transvaginal aspiration at the time of oocyte retrieval including the potential risk of infection associated with the puncture of a hydrosalpinx. The occurrence of infections in association with puncture of hydrosalpinx seems to be rare when antibiotics have been given according to the published reports. The method has the obvious advantage of being less invasive than the other available surgical methods. Today, there is no evidence that transvaginal aspiration is as effective as salpingectomy, but for patient who will not undergo salpingectomy and for those who develop tubal fluid during stimulation it is an option. 13 Strandell Medical treatment The use of antibiotics has also been discussed, not only as prophylactics when a hydrosalpinx has been punctured but also when given to selected groups of patients with elevated serum Chlamydia trachomatis IgG antibody titres or as a routine before oocyte retrieval to all patients (Sharara et al. 1996). However, antibiotic treatment specifically in hydrosalpinx patients has never been prospectively evaluated. One retrospective study has compared patients with hydrosalpinx who received extended doxycyclin treatment during an IVF cycle to patients with other indications (tubal occlusion without hydrosalpinx/ adhesions or endometriosis / unexplained infertility) who did not receive any antibiotics (Hurst et al. 2001). Implantation and pregnancy rates were similar in all groups, suggesting that antibiotic treatment would minimize the detrimental effect of hydrosalpinx. The method is advantageously cheap and simple, but its benefit still needs to be evaluated in a prospective trial. Conclusion In order to improve the chances of a full-term pregnancy in patients with hydrosalpinges undergoing IVF, different surgical approaches have been discussed. Salpingectomy is the only method that has been properly evaluated and from the Scandinavian study a clear recommendation has been formulated: Patients with hydrosalpinges large enough to be visible on ultrasound examination can be recommended laparoscopic salpingectomy prior to IVF in order to enhance their chance of a full term pregnancy. Less invasive methods like tubal ligation and transvaginal aspiration still awaits to be evaluated in a prospective well-designed trial. References Aboulghar,M.A., Mansour,R.T., Serour,G.I. et al. (1990) Transvaginal ultrasonic needle guided aspiration of pelvic inflammatory cystic masses before ovulation induction for in vitro fertilization. Fertil.Steril. 53, 311314. Dar,P., Sachs,G.S., Strassburger,D., et al. (2000) Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum.Reprod., 15, 142-144. Hurst,B.S., Tucker,K.E., Awoniyi,C.A., Schlaff,W.D. (2001) Hydrosalpinx treated with extended doxycyclin does not compromise the success of in vitro fertilization. Fertil.Steril., 75, 1017-1019. Lass,A., Ellenbogen,A., Croucher,C., et al. (1998) Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program. Fertil.Steril., 70, 1035-1038. 13 Strandell Sharara,F.I., Scott Jr,R.T., Marut,E.L. et al. (1996) In-vitro fertilization outcome in women with hydrosalpinx. Hum.Reprod., 11, 526-530. Sowter,M.C., Akande,V.A., Williams,J.A. et al. (1997) Is the outcome of in-vitro fertilization and embryo transfer treatment improved by spontaneous or surgical drainage of a hydrosalpinx? Hum.Reprod., 12, 2147-2150. Stadtmauer,L.A., Riehl,R.M., Toma,S.K. et al. (2000) Cauterization of hydrosalpinges before in vitro fertilization is an effective surgical treatment associated with improved pregnancy rates. Am.J.Obstet.Gynecol. 183, 367-371. Strandell,A., Lindhard,A., Waldenstrצm,U. et al. (1999) Hydrosalpinx and IVF outcome: A prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum.Reprod., 14, 27622769. Strandell,A., Lindhard,A., Waldenstrצm,U. et al. (2001) Salpingectomy prior to IVF does not impair the ovarian response. Hum.Reprod., 16, 1135-1139. Surrey,E.S., Schoolcraft,W.B. (2001) Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion. Fertil.Steril., 75, 612617. Van Voorhis,B.J., Sparks,A.E., Syrop,C.H. et al. (1998) Ultrasoundguided aspiration of hydrosalpinges is associated with improved pregnancy and implantation rates after in-vitro fertilization cycles. Hum.Reprod., 13, 736-739. 13 Strandell